Crossmark

Icatibant as an early rescue therapy in hypovolemic shock with converting enzyme inhibitor treatment

Crossref DOI link: https://doi.org/10.1186/s13054-017-1857-0

Published Online: 2017-11-02

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Charbonneau, Hélène https://orcid.org/0000-0003-2121-2283
Buléon, Marie

Richard, Benoit

Mayeur, Nicolas
License Information

Text and Data Mining valid from 2017-11-02
More Information

Article History

Received: 28 July 2017

Accepted: 5 October 2017

First Online: 2 November 2017

Ethics approval

: The animal experiments were performed according to the national and institutional animal care and ethical guidelines and were approved by the local board (Comité d’Ethique en matière d’Expérimentation Animale CEEA122 US006/CREFRE; reference CEEA122 2014-75). The animals used in this study were 18- to 24-week-old C57/BL6 wild-type mice (Harlan, Gannat, France).

: Not applicable.

: The authors declare that they have no competing interests with regard to the topic of this article.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.